Sumitomo Pharma Co., Ltd.

4506.T · JPX
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Assets
Cash & Equivalents¥23,116¥29,047¥143,478¥202,984
Short-Term Investments¥16,840¥7,085¥0¥0
Receivables¥74,840¥97,239¥95,908¥151,407
Inventory¥94,222¥115,350¥94,405¥99,021
Other Curr. Assets¥44,150¥37,064¥48,069¥46,109
Total Curr. Assets¥253,168¥269,569¥381,860¥499,521
Property Plant & Equip (Net)¥46,648¥57,895¥58,909¥64,091
Goodwill¥197,406¥199,783¥209,415¥195,144
Intangibles¥172,509¥195,652¥329,314¥398,692
Long-Term Investments¥56,501¥161,711¥113,833¥127,909
Tax Assets¥534¥0¥10,845¥22,650
Other NC Assets¥15,838¥22,896¥30,566¥0
Total NC Assets¥489,436¥637,937¥752,882¥808,486
Other Assets¥0¥0¥0¥0
Total Assets¥742,604¥907,506¥1,134,742¥1,308,007
Liabilities
Payables¥38,544¥67,720¥13,403¥22,455
Short-Term Debt¥46,440¥285,517¥90,588¥25,085
Tax Payable¥1,577¥1,348¥24,053¥7,583
Deferred Revenue¥0¥0¥151,952¥140,034
Other Curr. Liab.¥154,042¥158,456¥239,990¥201,642
Total Curr. Liab.¥240,603¥515,474¥372,694¥278,373
LT Debt¥258,982¥133,367¥244,128¥243,963
Deferred Rev, NC¥0¥0¥16,877¥27,932
Deferred Tax Liab, NC¥26,550¥38,211¥36,505¥26,550
Other NC Liab.¥41,520¥59,119¥50,760¥47,587
Total NC Liab.¥332,522¥235,896¥355,266¥356,065
Other Liabilities¥0¥0¥0¥0
Cap. Leases¥0¥5,199¥6,996¥10,033
Total Liabilities¥573,125¥751,370¥727,960¥634,438
Equity
Pref Stock¥0¥0¥0¥0
Common Stock¥22,400¥22,400¥22,400¥22,400
Retained Earnings¥46,784-¥22,665¥280,999¥514,210
AOCI¥100,977¥157,010¥104,032¥55,234
Other Equity¥0¥0¥0¥0
Total Equity¥169,479¥156,063¥406,749¥607,888
Supplemental Information
Minority Interest¥0¥73¥33¥65,681
Total Liab. & Tot. Equity¥742,604¥907,506¥1,134,742¥1,308,007
Net Debt¥282,306¥389,837¥191,238¥66,064